Schrodinger
Phase 1Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research.
Founded
1990
Focus
Small Molecules
About
Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research.
Funding History
5Total raised: $422M
IPO$232MUndisclosedFeb 6, 2020
Series D$85MUndisclosedSep 15, 2010
Series C$50MUndisclosedJun 15, 2005
Series B$35MUndisclosedNov 15, 2002
Company Info
TypePrivate
Founded1990
LocationNew York, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile